Influenza virus infection of mice induces anorexia: comparison with endotoxin and interleukin-1 and the effects of indomethacin

Pharmacol Biochem Behav. 1997 May-Jun;57(1-2):389-96. doi: 10.1016/s0091-3057(96)00335-8.

Abstract

The effects of infection of mice with influenza virus on ingestive behavior were assessed by both 22-h intake of food pellets, and intake of sweetened milk in a 30-minute access period. Infection with a lethal dose of virus resulted in losses in body weight as well as a reduction in food pellet intake. By contrast, infection with a sublethal dose of virus decreased body weight and food pellet intake to a lesser extent, but did not alter milk intake. Acute intraperitoneal injection of endotoxin (LPS, 0.3-5 micrograms), interleukin-1 alpha (IL-1 alpha, 50-100 ng) or IL-1 beta (100 ng) reduced milk intake, suggesting that the reduction of ingestive behavior may be associated with immune activation in general, and IL-1 in particular Pretreatment of the mice with the cyclooxygenase inhibitor, indomethacin (10 mg/kg SC) substantially attenuated, but did not completely reverse, the reduction in milk intake by LPS and IL-1. However, chronic treatment with indomethacin failed to alter the body weight or the intake of sweetened milk in influenza-infected mice, although there was some attenuation of the reduction in food intake. These results suggest that although IL-1 may play a role in the anorexia caused by influenza virus infection, it is not the only factor involved.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Analysis of Variance
  • Animals
  • Anorexia / etiology*
  • Cyclooxygenase Inhibitors / pharmacology*
  • Drug Evaluation, Preclinical
  • Feeding Behavior / drug effects
  • Indomethacin / pharmacology*
  • Interleukin-1 / antagonists & inhibitors*
  • Lethal Dose 50
  • Lipopolysaccharides / pharmacology*
  • Male
  • Mice
  • Mice, Inbred Strains
  • Motivation
  • Orthomyxoviridae Infections / complications*
  • Reward

Substances

  • Cyclooxygenase Inhibitors
  • Interleukin-1
  • Lipopolysaccharides
  • Indomethacin